Multidrug-resistant Fusarium in keratitis: a clinico-mycological study of keratitis infections in Chennai, India

Mycoses. 2017 Apr;60(4):230-233. doi: 10.1111/myc.12578. Epub 2016 Oct 21.

Abstract

In this study, we aimed to present the first molecular epidemiological data from Chennai, India, analyse keratitis cases that have been monitored in a university hospital during 2 years, identify the responsible Fusarium species and determine antifungal susceptibilities. A total of 10 cases of keratitis were included in the study. Fusarium isolates were identified using the second largest subunit of the RNA polymerase gene (RPB2) and the translation elongation factor 1 alpha (TEF1). Antifungal susceptibility was tested by the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) methodology. The aetiological agents belonged to Fusarium solani species complex (FSSC) (n = 9) and Fusarium sambucinum species complex (FSAMSC) (n = 1), and the identified species were Fusarium keratoplasticum (n = 7), Fusarium falciforme (n = 2) and Fusarium sporotrichioides (n = 1). All strains showed multidrug resistance to azoles and caspofungin but exhibited lower minimum inhibitory concentration (MIC) to natamycin and amphotericin B. Fusarium keratoplasticum and Fusarium falciforme belonging to the Fusarium solani species complex were the major aetiological agents of Fusarium keratitis in this study. Early presentation and 5% topical natamycin was associated with better patient outcome. Preventative measures and monitoring of local epidemiological data play an important role in clinical practice.

Keywords: Fusarium; RPB2; TEF1; antifungal resistance; keratomycosis; trauma.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Adult
  • Amphotericin B / pharmacology
  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use
  • Azoles / pharmacology
  • Caspofungin
  • Drug Resistance, Multiple, Fungal
  • Echinocandins / pharmacology
  • Female
  • Fusariosis / drug therapy
  • Fusariosis / epidemiology*
  • Fusariosis / microbiology
  • Fusarium / classification
  • Fusarium / drug effects*
  • Fusarium / genetics
  • Fusarium / isolation & purification
  • Genes, Fungal / genetics
  • Hospitals, University
  • Humans
  • India / epidemiology
  • Keratitis / drug therapy
  • Keratitis / epidemiology*
  • Keratitis / microbiology
  • Lipopeptides / pharmacology
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Natamycin / pharmacology
  • Natamycin / therapeutic use
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Azoles
  • Echinocandins
  • Lipopeptides
  • Amphotericin B
  • Natamycin
  • Caspofungin

Associated data

  • GENBANK/KU711749
  • GENBANK/KU604346
  • GENBANK/KU711750
  • GENBANK/KU604347
  • GENBANK/KU711751
  • GENBANK/KU604350
  • GENBANK/KU711728
  • GENBANK/KU604365
  • GENBANK/KU711752
  • GENBANK/KU604351
  • GENBANK/KU711755
  • GENBANK/KU604355
  • GENBANK/KU711753
  • GENBANK/KU604348
  • GENBANK/KU711754
  • GENBANK/KU604349
  • GENBANK/KU711729
  • GENBANK/KU604370
  • GENBANK/KU711720
  • GENBANK/KU604382